Engineering Psychoplastogens: Toward a Safer Alternative for Treating Depression
Identification of psychoplastogenic isoDMT analogs is a concrete step forward in using psychedelics for treating patients who suffer from depression.
Mental Health
What is the Mystical Experience Questionnaire?
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
The Effects of Psilocybin on Morality and Empathy
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits?
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
Equity and Accessibility of MDMA-Assisted Therapy
Psychedelic medicine continues to move forward, but minority communities are being left behind.
Methoxetamine: Cousin of Ketamine
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
It Takes Guts: Psychedelic Treatment Approaches to Autoimmune Disorders
There is much research into psychedelic treatment of mental disorders, but psychedelics might be effective in treating autoimmune disorders as well.
The Top 10 Psychedelic Research Papers of 2020
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
How to Change Your Ability to Change
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.